Being a type I acute phase protein, GlycA is induced by cytokines, interleukins and tumour necrosis factor alpha (TNFα) [41, 42], which among others stimulate a systemic inflammatory response in COPD patients who lose weight [43]. This evidence concerns the gene SGCG and chronic obstructive pulmonary disease.